Noroxin



Indications and Reactions:

Role Indications Reactions
Primary
Urinary Tract Infection 34.8%
Hypertension 12.3%
Cystitis 6.7%
Atrial Fibrillation 4.8%
Dyslipidaemia 3.9%
Pyrexia 3.7%
Prostatitis 3.5%
Abdominal Pain 3.0%
Prophylaxis 3.0%
Depression 2.8%
Diarrhoea 2.6%
Epilepsy 2.6%
Pain 2.6%
Bronchitis 2.4%
Drug Use For Unknown Indication 2.4%
Pyelonephritis 2.2%
Anxiety 1.9%
Arthralgia 1.7%
Dysuria 1.7%
Insomnia 1.5%
Tendonitis 8.8%
Drug Exposure During Pregnancy 8.0%
Pyrexia 7.2%
Tendon Disorder 7.2%
Toxic Skin Eruption 7.2%
Cytolytic Hepatitis 6.4%
Drug Eruption 6.4%
International Normalised Ratio Increased 6.4%
Rectal Haemorrhage 4.8%
Drug Interaction 4.0%
Jaundice 4.0%
Myalgia 4.0%
Paralysis 4.0%
Acute Generalised Exanthematous Pustulosis 3.2%
Interstitial Lung Disease 3.2%
Leukocytoclastic Vasculitis 3.2%
Renal Failure Acute 3.2%
Rhabdomyolysis 3.2%
Vomiting 3.2%
Intra-uterine Death 2.4%
Secondary
Urinary Tract Infection 23.9%
Drug Use For Unknown Indication 15.4%
Pyelonephritis 12.3%
Product Used For Unknown Indication 12.2%
Prophylaxis 4.1%
Hypertension 3.8%
Epilepsy 3.4%
Pyrexia 2.9%
Abdominal Pain 2.6%
Diabetes Mellitus 2.3%
Bronchitis 2.2%
Upper Respiratory Tract Inflammation 2.2%
Atrial Fibrillation 1.9%
Diarrhoea 1.9%
Cystitis 1.8%
Type 2 Diabetes Mellitus 1.6%
Renal Colic 1.5%
Bronchopneumopathy 1.3%
Depression 1.3%
Dyslipidaemia 1.2%
Tendon Disorder 51.4%
Drug Eruption 5.2%
Cytolytic Hepatitis 3.5%
Thrombocytopenia 3.5%
Urticaria 3.5%
Pyrexia 2.9%
Renal Failure Acute 2.9%
Vomiting 2.9%
Condition Aggravated 2.3%
Haemolytic Anaemia 2.3%
Leukopenia 2.3%
Pancreatitis Acute 2.3%
Urinary Tract Infection 2.3%
Vulvovaginal Dryness 2.3%
Hyponatraemia 1.7%
Myalgia 1.7%
Pancytopenia 1.7%
Pseudomembranous Colitis 1.7%
Red Blood Cell Count Decreased 1.7%
Rhabdomyolysis 1.7%
Concomitant
Drug Use For Unknown Indication 32.7%
Product Used For Unknown Indication 11.0%
Urinary Tract Infection 9.2%
Hypertension 8.5%
Hepatitis C 6.2%
Rheumatoid Arthritis 4.8%
Diabetes Mellitus 2.9%
Epilepsy 2.6%
Prophylaxis 2.6%
Depression 2.5%
Anaemia 2.2%
Unevaluable Event 2.1%
Ascites 1.8%
Gastrooesophageal Reflux Disease 1.8%
Multiple Myeloma 1.6%
Osteoporosis 1.6%
Pain 1.6%
Cystitis 1.5%
Sleep Disorder 1.5%
Essential Hypertension 1.3%
Stevens-johnson Syndrome 9.9%
Tremor 7.7%
Vomiting 7.7%
Renal Failure 6.6%
Renal Impairment 6.6%
Neutropenia 5.5%
Upper Limb Fracture 5.5%
White Blood Cell Count Decreased 5.5%
Anaemia 4.4%
Portal Vein Thrombosis 4.4%
Respiratory Failure 4.4%
Toxic Skin Eruption 4.4%
Visual Impairment 4.4%
Deep Vein Thrombosis 3.3%
Hepatic Encephalopathy 3.3%
Jaundice 3.3%
Oedema Peripheral 3.3%
Pruritus 3.3%
Pulmonary Embolism 3.3%
Pyrexia 3.3%
Interacting
Drug Use For Unknown Indication 34.8%
Urinary Tract Infection 13.0%
Atrial Fibrillation 8.7%
Chronic Myeloid Leukaemia 8.7%
Depression 8.7%
Abdominal Pain Upper 4.3%
Cystitis 4.3%
Hiatus Hernia 4.3%
Multiple Sclerosis 4.3%
Myocardial Ischaemia 4.3%
Pyelonephritis 4.3%
International Normalised Ratio Increased 22.2%
Urinary Tract Infection 22.2%
Drug Interaction 11.1%
Fall 11.1%
Liver Function Test Abnormal 11.1%
Rhabdomyolysis 11.1%
Vomiting 11.1%